SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Merck
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
1580 80 0 MRK
Emcee:  Alfred W. Post Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1505summary of BS MRK upgrade courtesy of Barron's Online... <b>Merck'Ian@SI-1/3/2007
1504Merck Wins Another Vioxx Trial By HEATHER WON TESORIERO December 14, 2006; Page mopgcw-12/14/2006
15038:30AM Merck says remains confident in future growth, remains on track to deliDoc Bones-12/12/2006
1502Merck Sees Vaccines, Cost Cuts Offsetting Zocor Slump in 2007 [WSJ] By PETER LODoc Bones-12/7/2006
1501Judge Rules Federal Vioxx Suits Can't Be Single Class-Action Case AssociateDoc Bones-11/24/2006
1500i am surprised stock didn't take off after favorable decision re no class achdl-11/23/2006
1499Vioxx cases not all big payoffs Wednesday, November 08, 2006 CHARLESTON - The TimF-11/16/2006
1498Merck Adds U.S., Canada Tax Disputes to Woes [WSJ] Liabilities in Four Cases CoDoc Bones-11/8/2006
1497Update -- Merck's $1 Billion Bet Matthew Herper, Robert Langreth and Peter Kmopgcw-11/3/2006
1496Inside Merck's Biotech Buy Kerry A. Dolan, 10.31.06, 10:00 AM ET Burlingamemopgcw-11/3/2006
1495gs: Merck & Co., Inc. EPS (FY Dec) 2006E $2.57, 2007E $2.39 Sell/Neutral (MRmopgcw-10/23/2006
1494Merck Is Victorious In New Orleans Vioxx Trial By HEATHER WON TESORIERO Septembmopgcw-9/27/2006
1493Mark Lanier on again disputing the MERCK/VIOXX report on CNBC. You either love Paul Chiu-9/7/2006
1492Merck's Possible Vioxx Successor Draws Mixed Results in Study [WSJ] By HEATDoc Bones-8/24/2006
1491Merck Loses Federal Vioxx Case A WALL STREET JOURNAL ONLINE NEWS ROUNDUP Augustmopgcw-8/17/2006
1490An Investigational Oral HIV Integrase Inhibitor, MK-0518, in Combination Therapyscaram(o)uche-8/12/2006
1489HIV Prevention Pill Clears Key Safety Hurdle By MARILYN CHASE August 12, 2006 9mopgcw-8/12/2006
1488wsj: Merck Wins California Vioxx Case, Widening Edge on Trial Score Card By ANDmopgcw-8/3/2006
1487gs: Merck & Co., Inc. (MRK): Maintaining below consensus view 52-Week Rangemopgcw-7/28/2006
1486Latest Verdict In Vioxx Suits Is Merck Victory By PETER LOFTUS and HEATHER WON mopgcw-7/14/2006
1485gs: MRK(U/N): Gardasil approved, in-line with our view 52-Week Range US$36-26 Ymopgcw-6/22/2006
1484Citi: MRK: Solid Januvia Data at the ADA HOLD (2) Medium Risk (M) mopgcw-6/22/2006
1483wsj: Research Chief Stirs Up Merck By Seeking Aid From Outsiders Kim Blasts mopgcw-6/7/2006
1482Why the Data Diverge on the Dangers of Vioxx [NYT] By ANDREW POLLACK and REED ADoc Bones-5/22/2006
1481New Merck Data Suggest Risks From Vioxx Begin Earlier in Use [WSJ] By HEATHER WDoc Bones-5/18/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News